Anne Bang joins research to understand the genetic underpinnings of psychiatric conditions

Scientists have linked neuropsychiatric disorders, such as schizophrenia and autism, to changes in many genes involved in early brain development.

Novartis eyes first-line status for its radionucleotide therapy Lutathera – Pharmaceutical Technology

Both of Novartis’ NET therapies were top 20 high-grossing drugs for the company, with Sandostatin and Lutathera generating $660m and $299m in H2 2023. Image

September 25, 2023

Inflammaging: The hidden cause of aging and age-related conditions

University of Virginia School of Medicine researchers have discovered a key driver of chronic inflammation that accelerates aging.

July 28, 2023

Gene therapy for sickle cell disease remains a tough business model — and may never work

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. The deep financial restructuring announced

September 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.